Mattessich Antony C. has filed 8 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 13000 shares of Aura Biosciences, Inc. ($AURA) on June 17, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Aura Biosciences, Inc. | $AURA | Mattessich Antony C. | Not found | A | Common Stock | 13000 | $0.00 | 23,500.0000 | 49,650,480 | 123.81% | 0.03% |
| June 17, 2025 | Aura Biosciences, Inc. | $AURA | Mattessich Antony C. | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 49,650,480 | 9999.99% | 0.03% |
| June 20, 2024 | Aura Biosciences, Inc. | $AURA | Mattessich Antony C. | Not found | A | Stock Option (Right to Buy) | 14500 | $0.00 | 14,500.0000 | 39,620,036 | 9999.99% | 0.04% |
| June 20, 2024 | Aura Biosciences, Inc. | $AURA | Mattessich Antony C. | Not found | A | Common Stock | 10500 | $0.00 | 10,500.0000 | 39,620,036 | 9999.99% | 0.03% |
| Feb. 3, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Mattessich Antony C. | President and CEO | A | Stock Option (Right to Buy) | 549400 | $0.00 | 549,400.0000 | 85,596,594 | 9999.99% | 0.64% |
| Feb. 5, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Mattessich Antony C. | President and CEO | S | Common Stock | 19642 | $4.86 | 595,201.0000 | 85,596,594 | 3.41% | 0.02% |
| Feb. 3, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Mattessich Antony C. | President and CEO | A | Common Stock | 180400 | $0.00 | 614,843.0000 | 85,596,594 | 41.52% | 0.21% |
| Jan. 31, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Mattessich Antony C. | President and CEO | S | Common Stock | 18338 | $4.95 | 434,443.0000 | 85,596,594 | 4.05% | 0.02% |